Monarch Partners Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Monarch Partners Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$4.16M	Sell
2022 Q3	$5.13M	Buy
2022 Q2	$4.16M	Buy
2016 Q4	–	Sell
2016 Q3	$3.5M	Buy